Literature DB >> 2905419

Activities of neuronal and astrocytic marker enzymes in autopsied brain tissue from patients with hepatic encephalopathy.

J Lavoie1, J F Giguère, G P Layrargues, R F Butterworth.   

Abstract

Activities of the gamma-aminobutyric acid (GABA) and cholinergic nerve-terminal marker enzymes glutamic acid decarboxylase (GAD) and choline acetyltransferase (CAT) as well as the astrocytic enzyme glutamine synthetase (GS) were measured in homogenates of dissected brain tissue obtained at autopsy from nine cirrhotic patients dying in hepatic encephalopathy and an equal number of control subjects matched for age, agonal status, and time interval from death to freezing of autopsied material. GAD activities varied as a function of agonal status in control samples, confirming a previous report, but were unchanged in brain tissue from cirrhotic patients, suggesting no loss of integrity of presynaptic GABA nerve terminals in this disease. On the other hand, GS activities were selectively decreased by 25% (P less than 0.01) in caudate nuclei of cirrhotic patients, reflecting, no doubt, the severe astrocytosis consistently observed in this brain structure. CAT activities, expressed per milligram of protein, were found to be increased by 30% (P less than 0.01) in the prefrontal cortex of cirrhotic patients. Whether such changes result from a relative increase in CAT as a consequence of losses of astrocytic protein or reflect altered cholinergic function in hepatic encephalopathy associated with chronic liver disease awaits further study.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2905419     DOI: 10.1007/BF00999698

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  22 in total

1.  A rapid radiochemical method for the determination of choline acetyltransferase.

Authors:  F Fonnum
Journal:  J Neurochem       Date:  1975-02       Impact factor: 5.372

2.  Enzymes associated with the metabolism of catecholamines, acetylcholine and gaba in human controls and patients with Parkinson's disease and Huntington's chorea.

Authors:  P L McGeer; E G McGeer
Journal:  J Neurochem       Date:  1976-01       Impact factor: 5.372

3.  Plasma and brain amino acids in fulminant hepatic failure and their relationship to hepatic encephalopathy.

Authors:  C O Record; B Buxton; R A Chase; G Curzon; I M Murray-Lyon; R Williams
Journal:  Eur J Clin Invest       Date:  1976-09-10       Impact factor: 4.686

4.  Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies.

Authors:  D M Bowen; C B Smith; P White; A N Davison
Journal:  Brain       Date:  1976-09       Impact factor: 13.501

5.  Stability of neuronal and glial marker enzymes in post-mortem rat brain.

Authors:  T Ritchie; S A Scully; J de Vellis; E P Noble
Journal:  Neurochem Res       Date:  1986-03       Impact factor: 3.996

6.  Amino acid changes in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.

Authors:  J Lavoie; J F Giguère; G P Layrargues; R F Butterworth
Journal:  J Neurochem       Date:  1987-09       Impact factor: 5.372

7.  Cerebral GABA-ergic and glutamatergic function in hepatic encephalopathy.

Authors:  R F Butterworth; J Lavoie; J F Giguère; G P Layrargues; M Bergeron
Journal:  Neurochem Pathol       Date:  1987 Feb-Apr

8.  Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue.

Authors:  E K Perry; P H Gibson; G Blessed; R H Perry; B E Tomlinson
Journal:  J Neurol Sci       Date:  1977-11       Impact factor: 3.181

Review 9.  Human brain neurochemistry - some postmortem problems.

Authors:  E K Perry; R H Perry
Journal:  Life Sci       Date:  1983-10-31       Impact factor: 5.037

10.  Ultrastructural study of methionine sulfoximine-induced Alzheimer type II astrocytosis.

Authors:  J A Gutierrez; M D Norenberg
Journal:  Am J Pathol       Date:  1977-02       Impact factor: 4.307

View more
  23 in total

Review 1.  Alterations of neurotransmitter-related gene expression in human and experimental portal-systemic encephalopathy.

Authors:  R F Butterworth
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

Review 2.  Neurotransmitter dysfunction in hepatic encephalopathy: new approaches and new findings.

Authors:  R F Butterworth
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

Review 3.  Pathogenesis and treatment of portal-systemic encephalopathy: an update.

Authors:  R F Butterworth
Journal:  Dig Dis Sci       Date:  1992-03       Impact factor: 3.199

4.  Rabbit retinal organ culture as an in-vitro model of hepatic retinopathy.

Authors:  Heidrun Kuhrt; Michał Walski; Andreas Reichenbach; Jan Albrecht
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-02-18       Impact factor: 3.117

Review 5.  Glutamatergic synaptic dysfunction in hyperammonemic syndromes.

Authors:  V L Rao; C R Murthy; R F Butterworth
Journal:  Metab Brain Dis       Date:  1992-03       Impact factor: 3.584

Review 6.  Neuronal cell death in hepatic encephalopathy.

Authors:  Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

Review 7.  Brain energy metabolism and mitochondrial dysfunction in acute and chronic hepatic encephalopathy.

Authors:  Kakulavarapu V Rama Rao; Michael D Norenberg
Journal:  Neurochem Int       Date:  2011-10-01       Impact factor: 3.921

8.  Effect of portacaval anastomosis on glutamine synthetase protein and gene expression in brain, liver and skeletal muscle.

Authors:  P Desjardins; K V Rao; A Michalak; C Rose; R F Butterworth
Journal:  Metab Brain Dis       Date:  1999-12       Impact factor: 3.584

Review 9.  Pathophysiology of alcoholic brain damage: synergistic effects of ethanol, thiamine deficiency and alcoholic liver disease.

Authors:  R F Butterworth
Journal:  Metab Brain Dis       Date:  1995-03       Impact factor: 3.584

10.  Effect of portacaval anastomosis on glutamine synthetase activities in liver, brain, and skeletal muscle.

Authors:  G Girard; R F Butterworth
Journal:  Dig Dis Sci       Date:  1992-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.